Viewing Study NCT07274761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:47 PM
Ignite Modification Date: 2025-12-28 @ 1:26 AM
Study NCT ID: NCT07274761
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-10
First Post: 2025-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer View
None Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small Cell Lung Cancer stage II-IIIB View
None Sunvozertinib View
None EGFR Exon 20 insertion View
None neoadjuvant View